Dr. Michelle Louise James's lab at Stanford University focuses on improving cancer immunotherapy, particularly through the development of imaging techniques that can track the activity of specialized T cells used in therapies like CAR T cell treatment. By creating advanced imaging agents, the lab aims to provide doctors with new tools to monitor and optimize these therapies for better patient outcomes. Their work seeks to enhance our understanding of how T cells behave in the body and improve treatment effectiveness for cancer patients.

Professor Guillem Pratx's lab at Stanford University focuses on developing advanced tumor models that closely mimic real human cancer tissues. By using innovative technologies like microfluidics and radioluminescence microscopy, the lab aims to create personalized models of tumors from patients, which can be used for drug discovery and to improve cancer treatment. Their research is designed to enhance the capability of imaging these models, making it possible to evaluate new therapies in a way that may lead to better patient outcomes.

Dr. Laura D. Attardi's lab focuses on understanding how the p53 gene helps suppress cancer. By studying its pathways and interactions, the lab aims to identify potential new treatments for various cancers like lung adenocarcinoma and hepatocellular carcinoma. The research uses advanced techniques like CRISPR and single-cell sequencing to gain insights into cancer biology and improve therapeutic strategies.